openPR Logo
Press release

Global Viral Gastroenteritis Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

05-06-2025 12:36 PM CET | Health & Medicine

Press release from: The Business Research Company

Viral Gastroenteritis

Viral Gastroenteritis

The Viral Gastroenteritis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Viral Gastroenteritis Market Size and Its Estimated Growth Rate?
There has been a consistent expansion in the viral gastroenteritis market in the last few years. It is projected to surge from $6.75 billion in 2024 to $7.08 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.0%. Factors that have led to this growth in the historic period include the prevalence of viral infections, improvements in global hygiene habits, advancements in diagnostic methods, the increase in worldwide travel and tourism, and changes in climate and environmental conditions.

The market size of viral gastroenteritis is anticipated to exhibit robust expansion in the upcoming years, reaching a value of $8.73 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. The predicted growth within this period is primarily due to improvements in global health readiness, the implications of climate change, the adoption of a one health approach, enhancements in epidemiological surveillance systems, and increased education and public awareness. Some emerging trends within this period consist of developing vaccines, sophisticated diagnostics, usage of telemedicine in diagnosis, combined research initiatives, techniques focusing on personalized medicine and deploying digital health solutions.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12127

How Are Emerging Segments Shaping the Viral Gastroenteritis Market Landscape?
The viral gastroenteritis market covered in this report is segmented -

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins
2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate
3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners
4) By Antimotility Agents: Loperamide, Diphenoxylate
5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

Which Growth Factors Are Influencing Viral Gastroenteritis Market Expansion?
The rise in gastrointestinal disorders is anticipated to boost the viral gastroenteritis market's expansion. Gastrointestinal (GI) disorders are diseases that affect any part of the gastrointestinal tract. Drugs and diagnosis treatments for viral gastroenteritis provide adequate medication to those afflicted by the disease. For example, the Impact of IBD Report 2023, issued by the IBD Clinical and Research Centre, a Canada-based organization committed to enhancing the quality of life for patients with Crohn's disease and ulcerative colitis, stated in September 2023 that the prevalence rate stood at 825 per 100,000 in 2023, with over 320,000 Canadians suffering from inflammatory bowel disease (IBD). The report projected, with an expected increase in prevalence by 2.44% annually, by 2035, 470,000 Canadians or 1.1% of the population would be living with IBD. Consequently, the escalating prevalence of gastrointestinal disorders is fueling the expansion of the viral gastroenteritis market.

Who Are the Dominant Players Across Different Viral Gastroenteritis Market Segments?
Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy's Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited

What Are the Latest Developing Trends in the Viral Gastroenteritis Market?
The focus on product innovation is a major trend emerging in the viral gastroenteritis market. Core firms functioning in this market are emphasizing the creation of new products to solidify their market standing. For example, in November 2022, GlaxoSmithKline PLC, a British biopharmaceutical corporation, gained approval from the US Food and Drug Administration (FDA) for their oral-dosing applicator-only presentation (liquid formulation) of ROTARIX, intended for preventing rotavirus gastroenteritis in infants. The convenience of this new formulation for healthcare providers is augmented by eliminating the necessity for the reconstitution of the vaccine dose at the point of use. The approval draws support from global clinical trial data that exhibits safety, tolerability compared to the lyophilized formulation, and non-inferior immunogenicity.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

Which Geographic Regions Are Expected to Dominate the Viral Gastroenteritis Market in the Coming Years?
North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Viral Gastroenteritis Market?
2. What is the CAGR expected in the Viral Gastroenteritis Market?
3. What Are the Key Innovations Transforming the Viral Gastroenteritis Industry?
4. Which Region Is Leading the Viral Gastroenteritis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Viral Gastroenteritis Market Outlook 2025-2034: Trends, Innovations, And Future Outlook here

News-ID: 4001418 • Views:

More Releases from The Business Research Company

Rising Disability Prevalence Fuels Expansion Of Stair Lifts And Climbing Devices Market: An Emerging Driver Transforming The Stair Lifts and Climbing Devices Market Landscape
Rising Disability Prevalence Fuels Expansion Of Stair Lifts And Climbing Devices …
The Stair Lifts and Climbing Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Stair Lifts and Climbing Devices Market? The market for stair lifts and climbing devices has experienced a quick expansion in previous years. The market, which
Global Scleroderma Market Analysis 2025-2030: Growth Drivers, Challenges, And Opportunities
Global Scleroderma Market Analysis 2025-2030: Growth Drivers, Challenges, And Op …
The Scleroderma Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Scleroderma Market Size Expected to Be by 2034? In the past few years, the scleroderma market has shown robust growth. It is projected to expand from $2.33 billion in 2024 to $2.49
Soybean Food And Beverage Products Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities
Soybean Food And Beverage Products Market Forecast 2025-2034: Comprehensive Anal …
The Soybean Food And Beverage Products Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Soybean Food And Beverage Products Market? The market size for soybean food and beverage products has witnessed significant expansion in the latest years. It is
Strong Growth Ahead: Running Shoes Market Size To Grow At Arecord 6.5% Cagr By 2029
Strong Growth Ahead: Running Shoes Market Size To Grow At Arecord 6.5% Cagr By 2 …
The Running Shoes Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Running Shoes Market Size Expected to Be by 2034? The market size of running shoes has witnessed a robust growth in the past few years. The market forecast shows an increase

All 5 Releases


More Releases for Viral

Viral Inactivation Market Growing Demand of Kits and Reagents Viral Inactivation …
According to Precision Business Insights (PBI), the latest report, the Viral Inactivation market is expected to be worth USD 2.1 billion in 2022, growing at a 12.8% CAGR from 2022 to 2028. The primary driver of the expansion of the global Viral Inactivation market are speedy growth in pharmaceutical and biotechnology industries and strong inclination of R&D investments in life sciences industry. View the detailed report description here - https://precisionbusinessinsights.com/market-reports/viral-inactivation-market/ Kits &
Global Anti-Viral Drug Therapy Market | Global Anti-Viral Drug Therapy Industry …
Anti-viral drug therapy market comprises of sales of branded & generic anti-viral drugs and related services by entities that manufacture the branded or generic anti-viral drugs for treating microbial infections. Anti-viral drug therapy industry includes several establishments that manufacture anti-viral drugs, which are used to treat diseases caused by viral infections. Examples of antiviral drugs include cidofovir, amantadine, zanamivir, idoxuridine, famiciclovir, tenofovir, adefovir and ribavirin. According to study, “Anti-Viral Drug Therapy
Viral Antigens Market to Reap Excessive Revenues by 2028(Based on product type, …
Antigens are commonly referred to as substances that are capable of triggering an immune response in a host by activating the lymphocytes or initiating antibody production against infections. Depending upon the fact that they either enter the human body or originate within the body, viral antigens are classified as foreign or self-antigens respectively. Among these, self-antigens comprise mutated or overexpressed proteins. However, foreign antigens are likely to include bacteria, parasites,
Viral Vector and Plasmid DNA Manufacturing Market - Increase In Awareness Regard …
The Viral Vector and Plasmid DNA Manufacturing Market is expected to reach $ 1,090 million in 2023, growing at an annual average rate of 22.6% from 2017 to 2023. North America was the largest contributor to the viral vector and plasmid DNA markets in 2016. However, the Asia Pacific region is expected to have the highest growth rate during the forecast period. Gene therapy has included tools such as viral vectors
Viral Vaccines Market : Challenges and Opportunities Against Viral Diseases
Vaccines are biotic compositions. They are basically formulated from living beings that increase the resistance against a specific illness. Vaccinations that help in avoiding the occurrence of specific diseases are known as prophylactic vaccines and in other instance, the vaccines that are helpful in treating the disease are called therapeutic vaccines. A vaccine is generally produced by using a weakened or murdered type of the sickness causing microorganism. The agent
Global Viral Molecular Diagnostics Market
The Viral Molecular Diagnostics Market reportprovides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease. Viral molecular diagnostic helps in